Related references
Note: Only part of the references are listed.Tetraspanin Proteins Regulate Membrane Type-1 Matrix Metalloproteinase-dependent Pericellular Proteolysis
Marc A. Lafleur et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells
Maria Yanez-Mo et al.
BLOOD (2008)
Activation of Matrix Metalloproteinase-2 (MMP-2) by Membrane Type 1 Matrix Metalloproteinase through an Artificial Receptor for ProMMP-2 Generates Active MMP-2
Yuki Nishida et al.
CANCER RESEARCH (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions
Takahisa Takino et al.
CANCER RESEARCH (2007)
Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels
Tomoya Kudo et al.
CANCER SCIENCE (2007)
MT1-MMP: A key regulator of cell migration in tissue
Yoshifumi Itoh
IUBMB LIFE (2006)
TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains
Charlotte J. Morrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tetraspanin functions and associated microdomains
ME Hemler
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and etastasis
H Sato et al.
CANCER SCIENCE (2005)
Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration
T Takino et al.
CANCER RESEARCH (2004)
Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice
J Oh et al.
ONCOGENE (2004)
TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metal loproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP
MM Bernardo et al.
BIOCHEMICAL JOURNAL (2003)
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction
S Hayashidani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase
T Takino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway
CJ Morrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases
H Miyamori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome
JA Martignetti et al.
NATURE GENETICS (2001)
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2
M Toth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation
S Hernandez-Barrantes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
ZJ Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
